Fresenius Kabi and sister
company Calea were fined more
than £550,000 last week in the UK
for supplying faulty syringes which
contained no active ingredient, in
this case, insulin.
A diabetic patient, Neil Judge
from Barnsley, died at the Northern
General Hospital in Sheffield in
November 2010, after treatment
with the syringes resulted in multiorgan
failure triggered by a serious
episode of diabetic ketoacidosis
because his body was deprived of
insulin for more than 13 hours.
The faulty syringes were
considered by the coroner to be
a ‘major contributory factor’ to
Judge’s death.
Inspections by the UK Medicines
Healthcare products Regulatory
Agency (MHRA) had highlighted
deficiencies.The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jul 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.